Belite Bio (BLTE) Amortization (2024 - 2025)
Belite Bio (BLTE) recorded quarterly Amortization of $1593.0 in Q3 2025, up 18.09% quarter-over-quarter from $1349.0 in Q4 2024.
Belite Bio (BLTE) Amortization (2024 - 2025) Analysis & Trends
Belite Bio's Amortization history runs 2 years deep, the most recent figure standing at $1593.0 for Q3 2025.
- In Q3 2025, Amortization changed N/A year-over-year to $1593.0; the TTM figure through Sep 2025 stood at $1593.0 (changed N/A YoY), while the FY2024 annual figure was $1349.0, changed N/A from the prior year.
- Amortization was $1593.0 for Q3 2025 at Belite Bio, up from $1349.0 in the prior quarter.
- In the past five years, Amortization ranged from a high of $1593.0 in Q3 2025 to a low of $1349.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -13.75 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1,593.00 |
| Sep 30, 2025 | 1,593.00 |
| Dec 31, 2024 | 1,349.00 |
| Dec 31, 2024 | 1,349.00 |